Spirocyclic NK1 antagonists I:: [4.5] and [5.5]-spiroketals

被引：25
|
作者：
Seward, EM
Carlson, E
Harrison, T
Haworth, KE
Herbert, R
Kelleher, FJ
Kurtz, MM
Moseley, J
Owen, SN
Owens, AP
Sadowski, SJ
Swain, CJ
Williams, BJ
机构：
[1] Merck Sharp & Dohme Res Labs, Dept Med Chem, Ctr Res Neurosci, Harlow, Essex, England
[2] Merck Sharp & Dohme Res Labs, Dept Pharmacol, Ctr Res Neurosci, Harlow, Essex, England
[3] Merck Res Labs, Dept Biochem, Rahway, NJ 07065 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2002年 / 12卷 / 18期
关键词：
D O I：
10.1016/S0960-894X(02)00506-1
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of novel spiroketal-based NK1 antagonists is described. The effect of modifications to the spiroether ring and aromatic substituents are discussed, leading to the identification of compounds with high affinity and excellent CNS penetration. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：2515 / 2518
页数：4
相关论文
共 50 条
  • [31] Correlation of neurokinin (NK) 1 receptor occupancy in gerbil striatum with behavioral effects of NK1 antagonists
    Duffy, RA
    Varty, GB
    Morgan, CA
    Lachowicz, JE
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (02): : 536 - 542
  • [32] Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonists
    Morriello, Gregori J.
    DeVita, Robert J.
    Mills, Sander G.
    Young, Jonathan R.
    Lin, Peter
    Doss, George
    Chicchi, Gary G.
    DeMartino, Julie
    Kurtz, Marc M.
    Tsao, Kwei-Lan C.
    Carlson, Emma
    Townson, Karen
    Wheeldon, Alan
    Boyce, Susan
    Collinson, Neil
    Rupniak, Nadia
    Moore, Stephen
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (05) : 2156 - 2170
  • [33] Antinociceptive properties of NK1 receptor antagonists on colorectal distension in rabbits
    Inatomi, N
    Okano, S
    Ikeura, Y
    Natsugari, H
    GASTROENTEROLOGY, 2001, 120 (05) : A641 - A641
  • [34] NK1 (substance P) receptor antagonists -: why are they not analgesic in humans?
    Hill, R
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (07) : 244 - 246
  • [35] Clinical experience with substance P receptor (NK1) antagonists in depression
    Krishnan, KRR
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 : 25 - 29
  • [36] NK1 receptor antagonists -: Are they really without effect in the pain clinic
    Urban, LA
    Fox, AJ
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (12) : 462 - 464
  • [37] High affinity phenylglycinol-based NK1 receptor antagonists
    Owens, AP
    Harrison, T
    Moseley, JD
    Swain, CJ
    Sadowski, S
    Cascieri, MA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (01) : 51 - 56
  • [38] Design and optimization of cyclized NK1 antagonists with controlled atropisomeric properties
    Albert, JS
    Ohnmacht, C
    Bernstein, PR
    Rumsey, WL
    Aharony, D
    Masek, BB
    Dembofsky, BT
    Koether, GM
    Potts, W
    Evenden, JL
    TETRAHEDRON, 2004, 60 (20) : 4337 - 4347
  • [39] THE EFFECTS OF CENTRALLY INJECTED NK1 RECEPTOR ANTAGONISTS ON EMESIS IN THE FERRET
    DAVISON, JS
    OLAND, L
    BOISSONADE, F
    GASTROENTEROLOGY, 1995, 108 (04) : A589 - A589
  • [40] Anti-emetic potential of tachykinin NK1 receptor antagonists
    J A RUDD
    M P NGAN
    M K WAI
    Acta Pharmacologica Sinica, 1999, (07) : 96 - 96
12345